Showing posts with label pain. Show all posts
Showing posts with label pain. Show all posts

2 December 2020

Chronic pain in adults 2017

Chronic pain in adults 2017
PHE 2 December 2020
  • An analysis of self-reported chronic pain from 2017 Health Survey for England data. It sets out the overall prevalence of chronic pain amongst the general population as well as identifying differences between sub-groups. It examines the site and severity of the chronic pain for those who are experiencing pain, as well as the impact on their mental health. It includes an analysis of chronic pain grade and use of a specialist pain service.

30 November 2019

A Systematic Review and Meta-analysis of Unguided Electronic and Mobile Health Technologies for Chronic Pain-Is It Time to Start Prescribing Electronic Health Applications?

A Systematic Review and Meta-analysis of Unguided Electronic and Mobile Health Technologies for Chronic Pain-Is It Time to Start Prescribing Electronic Health Applications?
Pain Medicine v20(11), p2238–2255, November 2019 DOI: 10.1093/pm/pnz164
  • This meta analysis (17 RCTs N=2496) found that electronic Health (ehealth) and mobile Health (mHealth) interventions that do not require clinician contact or feedback had significant effects on multiple short- and intermediate-term outcome measures recommended by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) guidelines in adults with chronic pain.

9 September 2019

Advanced Pain Discovery Platform

Advanced Pain Discovery Platform
Versus Arthritis 9 September 2019
  • A £24 million fund which forms a 5-year partnership between Versus Arthritis and UK Research and Innovation to generate a research platform, known as the Advanced Pain Discovery Platform, which will combine cutting edge technology and science, using artificial intelligence to understand the complex nature of pain in humans.

1 September 2019

Unrelieved Pain in Palliative Care in England

Unrelieved Pain in Palliative Care in England
OHE September 2019
  • This study estimates that currently there are approximately 125,971 end-of-life patients receiving, or in need of, palliative care suffering from unrelieved pain. Of these, an estimated 16,130 patients experience no relief from their pain at all in the last three months of life. There are variations in the quality of care across care settings (e.g. hospice versus at home services).

8 August 2019

Adult Highly Specialist Pain Management Services

Adult Highly Specialist Pain Management Services
NHS England 8 August 2019
  • This service specification covers the provision of adult highly specialist pain management services, but there are significant overlaps in relation to young people and the transition from children to adult services. There is a separate service specification for paediatric chronic pain (under the remit of specialised surgery in children).

31 January 2019

Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain

Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain [MTG41]
NICE medical technologies guidance January 2019
  • The case for adopting Senza spinal cord stimulation (SCS) for delivering HF10 therapy as a treatment option for chronic neuropathic back or leg pain after failed back surgery is supported by the evidence. 
  • NICE has developed tools, in association with relevant stakeholders, to help organisations put this guidance into practice.

30 November 2018

Cost-Effectiveness of Bone SPECT/CT in Painful Total Knee Arthroplasty.

Cost-Effectiveness of Bone SPECT/CT in Painful Total Knee Arthroplasty
J Nucl Med. 2018 Nov;59(11):1742-1750
  • The purpose of this study was to quantify the economic value of bone SPECT/CT versus CT or metal artifact reduction sequence (MARS)-MRI for the diagnostic assessment of recurrent moderate-to-severe pain after total knee arthroplasty (TKA). 

Abstract

21 November 2018

Brain and spinal stimulation therapies for phantom limb pain: a systematic review

Brain and spinal stimulation therapies for phantom limb pain: a systematic review
Health Technology Assessment 22(62) November 2018. https://doi.org/10.3310/hta22620
  • Studies of neurostimulation treatments did not provide robust results; therefore, there is much uncertainty about which treatments are best for chronic phantom limb pain.

31 October 2018

gammaCore for cluster headache

gammaCore for cluster headache
NICE Medtech innovation briefing [MIB162] October 2018
  • gammaCore is used as a daily preventative measure for cluster headache and can be used to treat pain during a headache. gammaCore is applied to the surface of the neck rather than surgically implanted.
  • Current research indicates that use of gammaCore alongside standard care may be more effective than standard care only in treating cluster headaches.

31 July 2018

Complex regional pain syndrome in adults: UK guidelines 2ed.

Complex regional pain syndrome in adults: UK guidelines for diagnosis, referral and management in primary and secondary care. 2ed.
Royal College of Physicians July 2018
  • Updated for 2018, these guidelines provide recommendations for diagnosis, treatment and referral in a variety of clinical settings, including:
    • primary care
    • occupational therapy and physiotherapy
    • surgical practice
    • rheumatology
    • neurology and neurosurgery
    • sport and exercise medicine
    • dermatology
    • pain medicine
    • rehabilitation medicine
    • emergency medicine
    • long-term care.

1 May 2018

The Edinburgh Pain Assessment and Management Tool in cancer inpatients

Pain Management in Cancer Center Inpatients: A Cluster Randomized Trial to Evaluate a Systematic Integrated Approach—The Edinburgh Pain Assessment and Management Tool
Journal of Clinical Oncology 2018 36:13, 1284-1290
  • This study compared the effect of adding a clinician-delivered bedside pain assessment and management tool (Edinburgh Pain Assessment and management Tool [EPAT]) to usual care (UC) versus UC alone on pain outcomes in inpatients in cancer centres (n=1,795). Results demonstrate that the EPAT tool demonstrated a significant improvement in worst pain without increasing opioid adverse effects.
  • Study: Two-arm, parallel group, cluster randomised (1:1) trial in 19 cancer centres in the United Kingdom involving 1,795 patients. Primary outcome - change in the percentage of study participants in each centre with a clinically significant (≥ 2 point) improvement in worst pain (using the Brief Pain Inventory Short Form) from admission to 3 to 5 days after admission. Secondary outcomes included quality of analgesic prescribing and opioid-related adverse effects.

20 March 2018

The impact of relocation of chronic pain service from hospital setting to community centre on patient experience: a single-centre audit

The impact of relocation of chronic pain service from hospital setting to community centre on patient experience
British Journal of Pain v12(2), pp. 122 - 131 20 March 2018, https://doi.org/10.1177/2049463718759782
  • Examination of patient experience of relocation of Lothian Chronic Pain Service (Edinburgh, Scotland)  from a university teaching hospital to a community setting found no clear evidence that Patient-Reported Experience Measure was negatively affected by the move. 
Abstract

16 March 2018

Non-invasive brain stimulation techniques for chronic pain.

Non-invasive brain stimulation techniques for chronic pain.
Cochrane Database of Systematic Reviews 2018, Updated April 2018 Issue 4. Art. No.: CD008208. DOI: 10.1002/14651858.CD008208.pub5.
  • An updated review of non-invasive brain simulation techniques for chronic pain has identified 94 RCTs of the five treatment types - 42 of repetitive transcranial magnetic stimulation (rDCS), 11 of cranial electrotherapy stimulation CES), 36 of transcranial direct current stimulation tDCS), two of reduced impedance non-invasive cortical electrostimulation (RINCE), two of transcranial random noise stimulation (tRNS) and one study which evaluated both tDCS and rTMS).
  • Key findings
    • rTMS applied to the motor cortex may lead to small, short-term reductions in pain but these effects are not likely to be clinically important. tDCS may reduce pain when compared with sham but for rTMS and tDCS our estimates of benefit are likely to be exaggerated by the small number of participants in each of the studies and limitations in the way the studies were conducted. Low- or very low-quality evidence suggests that low-frequency rTMS and rTMS that is applied to prefrontal areas of the brain are not effective. Low-quality evidence does not suggest that CES is an effective treatment for chronic pain. For all forms of stimulation the evidence is not conclusive and there is substantial uncertainty about the possible benefits and harms of the treatment. Of the studies that clearly reported side effects, short-lived and minor side effects such as headache, nausea and skin irritation were usually reported both with real and sham stimulation. Two cases of seizure were reported following real rTMS. Our conclusions for rTMS, CES, tDCS, and RINCE have not changed substantially in this update.

4 January 2018

Wearable mHealth Device for Chronic Pain Management

UK Approves Wearable mHealth Device for Chronic Pain Management
MHealthIntellligence 4 January 2018
  • The NHS has given its approval to the ActiPatch, a wearable device that manages peripheral nerve activity to help users suffering from pain.
  • NHS approval was linked to a study in which treatment with the mHealth wearable helped reducers reduce their trips to the doctor’s office by almost 60 percent and cut prescription drug costs by 35 percent, resulting in an overall reduction in healthcare costs of 45 percent.